Annual Retained Earnings
-$167.76 M
-$13.98 M-9.09%
December 31, 2023
Summary
- As of February 26, 2025, POAI annual retained earnings is -$167.76 million, with the most recent change of -$13.98 million (-9.09%) on December 31, 2023.
- During the last 3 years, POAI annual retained earnings has fallen by -$59.38 million (-54.79%).
- POAI annual retained earnings is now -5236.28% below its all-time high of -$3.14 million, reached on December 31, 2008.
Performance
POAI Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$178.26 M
-$3.09 M-1.77%
September 30, 2024
Summary
- As of February 26, 2025, POAI quarterly retained earnings is -$178.26 million, with the most recent change of -$3.09 million (-1.77%) on September 30, 2024.
- Over the past year, POAI quarterly retained earnings has stayed the same.
- POAI quarterly retained earnings is now -5570.10% below its all-time high of -$3.14 million, reached on December 31, 2008.
Performance
POAI Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
POAI Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -9.1% | 0.0% |
| 3 y3 years | -54.8% | -10.6% |
| 5 y5 years | -165.8% | -10.6% |
POAI Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -31.0% | at low | -39.2% | at low |
| 5 y | 5-year | -103.3% | at low | -116.1% | at low |
| alltime | all time | -5236.3% | at low | -5570.1% | at low |
Predictive Oncology Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$178.26 M(+1.8%) |
| Jun 2024 | - | -$175.16 M(+1.8%) |
| Mar 2024 | - | -$171.98 M(+2.5%) |
| Dec 2023 | -$167.76 M(+9.1%) | -$167.76 M(+2.1%) |
| Sep 2023 | - | -$164.29 M(+2.0%) |
| Jun 2023 | - | -$161.12 M(+2.5%) |
| Mar 2023 | - | -$157.20 M(+2.2%) |
| Dec 2022 | -$153.78 M(+20.1%) | -$153.78 M(+5.4%) |
| Sep 2022 | - | -$145.86 M(+2.9%) |
| Jun 2022 | - | -$141.80 M(+7.9%) |
| Mar 2022 | - | -$131.41 M(+2.6%) |
| Dec 2021 | -$128.04 M(+18.1%) | -$128.04 M(+6.4%) |
| Sep 2021 | - | -$120.28 M(+4.7%) |
| Jun 2021 | - | -$114.85 M(+2.3%) |
| Mar 2021 | - | -$112.27 M(+3.6%) |
| Dec 2020 | -$108.38 M(+31.4%) | -$108.38 M(+11.8%) |
| Sep 2020 | - | -$96.91 M(+7.0%) |
| Jun 2020 | - | -$90.61 M(+4.1%) |
| Mar 2020 | - | -$87.03 M(+5.5%) |
| Dec 2019 | -$82.50 M(+30.7%) | -$82.50 M(+19.7%) |
| Sep 2019 | - | -$68.94 M(+6.2%) |
| Jun 2019 | - | -$64.94 M(-2.2%) |
| Mar 2019 | - | -$66.40 M(+5.2%) |
| Dec 2018 | -$63.11 M(+19.0%) | -$63.11 M(+2.8%) |
| Sep 2018 | - | -$61.41 M(+4.3%) |
| Jun 2018 | - | -$58.90 M(+4.2%) |
| Mar 2018 | - | -$56.53 M(+6.6%) |
| Dec 2017 | -$53.02 M(+12.8%) | -$53.02 M(+2.2%) |
| Sep 2017 | - | -$51.90 M(+1.9%) |
| Jun 2017 | - | -$50.90 M(+5.3%) |
| Mar 2017 | - | -$48.36 M(+2.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2016 | -$47.02 M(+16.1%) | -$47.02 M(+1.6%) |
| Sep 2016 | - | -$46.29 M(+2.3%) |
| Jun 2016 | - | -$45.23 M(+6.0%) |
| Mar 2016 | - | -$42.67 M(+5.4%) |
| Dec 2015 | -$40.49 M(+13.6%) | -$40.49 M(+5.9%) |
| Sep 2015 | - | -$38.23 M(+3.0%) |
| Jun 2015 | - | -$37.11 M(+3.4%) |
| Mar 2015 | - | -$35.90 M(+0.7%) |
| Dec 2014 | -$35.64 M(+24.2%) | -$35.64 M(+7.2%) |
| Sep 2014 | - | -$33.25 M(+3.6%) |
| Jun 2014 | - | -$32.10 M(+5.8%) |
| Mar 2014 | - | -$30.33 M(+5.7%) |
| Dec 2013 | -$28.70 M(+48.8%) | -$28.70 M(+8.1%) |
| Sep 2013 | - | -$26.54 M(+17.6%) |
| Jun 2013 | - | -$22.57 M(+5.5%) |
| Mar 2013 | - | -$21.39 M(+10.9%) |
| Dec 2012 | -$19.29 M(+62.5%) | -$19.29 M(+9.8%) |
| Sep 2012 | - | -$17.57 M(+19.4%) |
| Jun 2012 | - | -$14.72 M(+17.0%) |
| Mar 2012 | - | -$12.58 M(+6.0%) |
| Dec 2011 | -$11.87 M(+60.8%) | -$11.87 M(+33.3%) |
| Sep 2011 | - | -$8.90 M(+7.9%) |
| Jun 2011 | - | -$8.25 M(+4.9%) |
| Mar 2011 | - | -$7.86 M(+6.5%) |
| Dec 2010 | -$7.38 M(+22.4%) | -$7.38 M(+5.7%) |
| Sep 2010 | - | -$6.99 M(+2.3%) |
| Jun 2010 | - | -$6.83 M(+0.7%) |
| Mar 2010 | - | -$6.78 M(+12.5%) |
| Dec 2009 | -$6.03 M(+91.8%) | -$6.03 M(+6.7%) |
| Sep 2009 | - | -$5.65 M(+79.8%) |
| Dec 2008 | -$3.14 M | -$3.14 M |
FAQ
- What is Predictive Oncology annual retained earnings?
- What is the all time high annual retained earnings for Predictive Oncology?
- What is Predictive Oncology annual retained earnings year-on-year change?
- What is Predictive Oncology quarterly retained earnings?
- What is the all time high quarterly retained earnings for Predictive Oncology?
- What is Predictive Oncology quarterly retained earnings year-on-year change?
What is Predictive Oncology annual retained earnings?
The current annual retained earnings of POAI is -$167.76 M
What is the all time high annual retained earnings for Predictive Oncology?
Predictive Oncology all-time high annual retained earnings is -$3.14 M
What is Predictive Oncology annual retained earnings year-on-year change?
Over the past year, POAI annual retained earnings has changed by -$13.98 M (-9.09%)
What is Predictive Oncology quarterly retained earnings?
The current quarterly retained earnings of POAI is -$178.26 M
What is the all time high quarterly retained earnings for Predictive Oncology?
Predictive Oncology all-time high quarterly retained earnings is -$3.14 M
What is Predictive Oncology quarterly retained earnings year-on-year change?
Over the past year, POAI quarterly retained earnings has changed by $0.00 (0.00%)